Abstract: Eosinophilic fasciitis is a rare sclerodermiform syndrome of unknown etiology. It is characterized by the thickening of the muscular fascia and subcutaneous tissue, with a variable infiltration of eosinophils. Peripheral eosinophilia, poly or monoclonal hypergammaglobulinemia and increased erythrocyte sedimentation rate can be seen. Clinical features begin acutely, with local edema and a painful and symmetrical stiffening of the limbs, progressing rapidly to fibrosis, which can limit joint movements. Some cases have a history of strenuous physical exercise or trauma. The diagnosis is confirmed by a deep skin biopsy. Glucocorticoids in high doses is the treatment of choice. We report a typical eosinophilic fasciitis case with peripheral eosinophilia and dramatic response to pulse therapy with methylprednisolone.
INTRODUCTION
Eosinophilic fasciitis (EF), or Shulman syndrome, was first described in 1974 as a variant of scleroderma with eosinophilia and fasciitis. However, the absence of sclerodactily, Raynaud's phenomenon, visceral involvement and a good response to systemic therapy with glucocorticoids distinguished this syndrome as its own entity.
It is a rare disease of unknown etiology, with less than 300 cases reported. ©2016 by Anais Brasileiros de Dermatologia Lamback EB, Resende FSS, Lenzi TCR mobility. EF typically presents with a linear depression that follows the path of the vessels in the affected area, know as Groove sign.
CASE REPORT
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The presence of a Groove sign and the absence of sclerodactily or Raynaud's phenomenon distinguishes EF from scleroderma. The face and hands are commonly unaffected. 
